Daniel Sandi

Szeged, CS, Hungary

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

Reliable Change Indices and Standardized Regression Norms for the Hungarian version of the BICAMS questionnaire.

Reliable Change Indices and Standardized Regression Norms for the Hungarian version of the BICAMS questionnaire.

Journal: Multiple sclerosis and related disorders

Published: January 20, 2025

A race against time: POEMS syndrome

A race against time: POEMS syndrome

Journal: Ideggyogyaszati szemle

Published: June 03, 2024

Fatigue and depression influence the prevalence of anxiety in patients with multiple sclerosis.

Fatigue and depression influence the prevalence of anxiety in patients with multiple sclerosis.

Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology

Published: May 09, 2024

The 7-year follow-up of the Hungarian BICAMS validation cohort implies that cognitive performance may improve in multiple sclerosis patients.

The 7-year follow-up of the Hungarian BICAMS validation cohort implies that cognitive performance may improve in multiple sclerosis patients.

Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology

Published: November 15, 2023

NEDA-state, psychological symptoms and quality of life are stable in natalizumab-treated multiple sclerosis patients: An up to 6-years long follow-up study.

NEDA-state, psychological symptoms and quality of life are stable in natalizumab-treated multiple sclerosis patients: An up to 6-years long follow-up study.

Journal: Heliyon

Published: January 31, 2023

Real-world operation of multiple sclerosis centres in Central-Eastern European countries covering 107 million inhabitants.

Real-world operation of multiple sclerosis centres in Central-Eastern European countries covering 107 million inhabitants.

Journal: Multiple sclerosis and related disorders

Published: April 27, 2022

Proteomics in Multiple Sclerosis: The Perspective of the Clinician.

Proteomics in Multiple Sclerosis: The Perspective of the Clinician.

Journal: International journal of molecular sciences

Published: March 29, 2022

Emerging Biomarkers of Multiple Sclerosis in the Blood and the CSF: A Focus on Neurofilaments and Therapeutic Considerations.

Emerging Biomarkers of Multiple Sclerosis in the Blood and the CSF: A Focus on Neurofilaments and Therapeutic Considerations.

Journal: International journal of molecular sciences

Published: February 24, 2022

The safety and efficacy of fingolimod: Real-world data from a long-term, non-interventional study on the treatment of RRMS patients spanning up to 5 years from Hungary.

The safety and efficacy of fingolimod: Real-world data from a long-term, non-interventional study on the treatment of RRMS patients spanning up to 5 years from Hungary.

Journal: PloS one

Published: December 15, 2021

Do Hungarian multiple sclerosis care units fulfil international criteria?

Do Hungarian multiple sclerosis care units fulfil international criteria?

Journal: PloS one

Published: October 20, 2021

Neurodegeneration in Multiple Sclerosis: Symptoms of Silent Progression, Biomarkers and Neuroprotective Therapy-Kynurenines Are Important Players.

Neurodegeneration in Multiple Sclerosis: Symptoms of Silent Progression, Biomarkers and Neuroprotective Therapy-Kynurenines Are Important Players.

Journal: Molecules (Basel, Switzerland)

Published: May 03, 2021

Connection between microstructural alterations detected by diffusion MRI and cognitive dysfunction in MS: A model-free analysis approach.

Connection between microstructural alterations detected by diffusion MRI and cognitive dysfunction in MS: A model-free analysis approach.

Journal: Multiple sclerosis and related disorders

Published: April 12, 2021

Showing 1-12 of 24

Last Updated: 09/26/2026